Bath & Body Works (NYSE:BBWI) Price Target Lowered to $40.00 at Citigroup

Bath & Body Works (NYSE:BBWI) had its price objective cut by Citigroup from $42.00 to $40.00 in a research report report published on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.

Other research analysts have also recently issued reports about the company. UBS Group raised their target price on Bath & Body Works from $32.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 20th. Wall Street Zen cut shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. JPMorgan Chase & Co. raised their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an “overweight” rating in a report on Monday, July 28th. Barclays reduced their price objective on Bath & Body Works from $35.00 to $30.00 and set an “equal weight” rating on the stock in a research note on Friday, May 30th. Finally, Morgan Stanley lowered their target price on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating for the company in a research report on Tuesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $42.06.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $29.8530 on Tuesday. The company has a market cap of $6.32 billion, a PE ratio of 7.96, a P/E/G ratio of 1.01 and a beta of 1.54. The firm’s 50 day moving average price is $30.05 and its 200-day moving average price is $31.15. Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion during the quarter, compared to analysts’ expectations of $1.42 billion. During the same quarter in the previous year, the business earned $0.38 earnings per share. The company’s revenue was up 2.9% on a year-over-year basis. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 21.33%.

Institutional Trading of Bath & Body Works

Institutional investors have recently added to or reduced their stakes in the company. Victory Capital Management Inc. lifted its stake in shares of Bath & Body Works by 14,732.0% during the 1st quarter. Victory Capital Management Inc. now owns 6,798,108 shares of the company’s stock worth $206,119,000 after acquiring an additional 6,752,274 shares during the last quarter. AQR Capital Management LLC increased its stake in Bath & Body Works by 267.8% in the first quarter. AQR Capital Management LLC now owns 3,993,173 shares of the company’s stock worth $121,073,000 after purchasing an additional 2,907,506 shares during the period. D1 Capital Partners L.P. bought a new stake in shares of Bath & Body Works during the fourth quarter worth $109,797,000. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Bath & Body Works by 115.7% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 3,680,104 shares of the company’s stock valued at $111,581,000 after purchasing an additional 1,973,679 shares during the period. Finally, Norges Bank purchased a new stake in shares of Bath & Body Works during the second quarter valued at $57,746,000. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.